Evidence map›Paper›PMID 38384997›Full record

ArticleBrain communications2024

Elijah Mak, Maria-Eleni Dounavi, Grégory Operto, Elina T Ziukelis, Peter Simon Jones, Audrey Low, Peter Swann, Coco Newton, Graciela Muniz Terrera, Paresh Malhotra and 12 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1.Epileptic disorders : international epilepsy journal with videotape · 2026
    Article
  2. Article
  3. Article
  4. APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individuals.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Hypothalamic volume, sleep, and APOE genotype in cognitively healthy adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 4 countries.

Elijah MakDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID https://orcid.org/0000-0002-6437-8024
Maria-Eleni DounaviDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID https://orcid.org/0000-0001-8287-346X
Grégory OpertoBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona 08005, Spain.
Elina T ZiukelisDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Peter Simon JonesDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.
Audrey LowDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID https://orcid.org/0000-0002-2520-454X
Peter SwannDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Coco NewtonDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID https://orcid.org/0000-0002-0937-9673
Graciela Muniz TerreraCentre for Dementia Prevention, University of Edinburgh, Edinburgh EH4 2XU, UK.
Paresh MalhotraDepartment of Brain Sciences, Imperial College, London W12 0NN, UK.ORCID https://orcid.org/0000-0002-1897-0780
Ivan KoychevDepartment of Psychiatry, Oxford University, Oxford OX3 7JX, UK.ORCID https://orcid.org/0000-0001-6813-8493
Carles FalconBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona 08005, Spain.
Clare MackayDepartment of Psychiatry, Oxford University, Oxford OX3 7JX, UK.ORCID https://orcid.org/0000-0001-6111-8318
Brian LawlorInstitute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin D02 PX31, Ireland.
Lorina NaciInstitute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin D02 PX31, Ireland.
Katie WellsCentre for Dementia Prevention, University of Edinburgh, Edinburgh EH4 2XU, UK.
Craig RitchieCentre for Dementia Prevention, University of Edinburgh, Edinburgh EH4 2XU, UK.
Karen RitchieInstitut National de la Santé et de la Recherche Médicale, U1061 Neuropsychiatrie, Montpellier 34093, France.
Li SuDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Juan Domingo GispertBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona 08005, Spain.ORCID https://orcid.org/0000-0002-6155-0642
John T O'BrienDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID https://orcid.org/0000-0002-0837-5080
PREVENT-Dementia and ALFA studies
University of Cambridge · GBTrinity College Dublin · IEUniversity of Edinburgh · GBBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESUniversity of Oxford · GBInserm · FRImperial College London · GBPasqual Maragall Foundation · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The apolipoprotein E ɛ4 allele is the primary genetic risk factor for the sporadic type of Alzheimer's disease. However, the mechanisms by which apolipoprotein E ɛ4 are associated with neurodegeneration are still poorly understood. We applied the Neurite Orientation Dispersion Model to characterize the effects of apolipoprotein ɛ4 and its interactions with age and education on cortical microstructure in cognitively normal individuals. Data from 1954 participants were included from the PREVENT-Dementia and ALFA (ALzheimer and FAmilies) studies (mean age = 57, 1197 non-carriers and 757 apolipoprotein E ɛ4 carriers). Structural MRI datasets were processed with FreeSurfer v7.2. The Microstructure Diffusion Toolbox was used to derive Orientation Dispersion Index maps from diffusion MRI datasets. Primary analyses were focused on (i) the main effects of apolipoprotein E ɛ4, and (ii) the interactions of apolipoprotein E ɛ4 with age and education on lobar and vertex-wise Orientation Dispersion Index and implemented using Permutation Analysis of Linear Models. There were apolipoprotein E ɛ4 × age interactions in the temporo-parietal and frontal lobes, indicating steeper age-dependent Orientation Dispersion Index changes in apolipoprotein E ɛ4 carriers. Steeper age-related Orientation Dispersion Index declines were observed among apolipoprotein E ɛ4 carriers with lower years of education. We demonstrated that apolipoprotein E ɛ4 worsened age-related Orientation Dispersion Index decreases in brain regions typically associated with atrophy patterns of Alzheimer's disease. This finding also suggests that apolipoprotein E ɛ4 may hasten the onset age of dementia by accelerating age-dependent reductions in cortical Orientation Dispersion Index.

Indexed as

cognitive impairmentneurodegenerationNODDIpreclinical dementia

Identifiers

PMID38384997
PMCPMC10881196
OpenAlexW4391991377

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.